-
CRMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CorMedix (CRMD)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm |
Cash burn (monthly) | (no burn) | 1.51 mm | 1.10 mm | 4.25 mm | 4.55 mm | 4.65 mm |
Cash used (since last report) | n/a | 7.65 mm | 5.56 mm | 21.54 mm | 23.07 mm | 23.56 mm |
Cash remaining | n/a | 27.74 mm | 29.83 mm | 13.86 mm | 12.32 mm | 11.83 mm |
Runway (months of cash) | n/a | 18.4 | 27.2 | 3.3 | 2.7 | 2.5 |
13F holders | Current |
---|---|
Total holders | 127 |
Opened positions | 39 |
Closed positions | 14 |
Increased positions | 49 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 178.53 bn |
Total shares | 22.79 mm |
Total puts | 400.50 k |
Total calls | 599.20 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 4.57 mm | $37.00 bn |
Vanguard | 3.38 mm | $27.36 bn |
Elliott Investment Management | 2.87 mm | $23.25 bn |
STT State Street | 1.45 mm | $11.77 bn |
Geode Capital Management | 1.39 mm | $11.28 bn |
First Turn Management | 1.02 mm | $8.27 bn |
NTRS Northern Trust | 511.57 k | $4.14 bn |
J. Goldman & Co | 457.32 k | $3.70 bn |
D. E. Shaw & Co. | 446.41 k | $3.62 bn |
MS Morgan Stanley | 398.85 k | $3.23 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Gregory Scott Duncan | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |
17 Jan 25 | Steven W Lefkowitz | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 100,498 |
17 Jan 25 | Kaplan Myron | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 176,034 |
17 Jan 25 | Dillione Janet | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 78,473 |
17 Jan 25 | Robert A Stewart | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 36,000 |